Question follow-through · 3591
Hyperemesis Gravidarum
To ask the Secretary of State for Health and Social Care, when NHS England last reviewed guidance for hyperemesis gravidarum; and whether that review was shared with (a) the Scottish Government and (b) NHS Scotland.
About this written question
A written question asks a government minister for information in writing. Parliament publishes the question and any answer.
- Answering body
- Department of Health and Social Care
- Tabled
- 30 Aug 2024
- Target answer date
- 3 Sept 2024
- Answer
- 9 Sept 2024 · 10 calendar days after tabling
Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.
More questions by this MP on Health and care
- Heart Diseases: Gender · 20 Jan 2025
- Drugs: Gender · 20 Jan 2025
- Drugs: Gender · 20 Jan 2025
- Drugs: Women · 20 Jan 2025
- Endometriosis: Research · 20 Jan 2025
Shared topic keywords suggest a connection; they do not establish a follow-up.
Votes on this topic
- Terminally Ill Adults (End of Life) Bill: Second Reading · 11 Sept 2026
- Health Bill: Report Stage: Amendment 1 · 8 Sept 2026
- Health Bill: Report Stage: New Clause 143 · 8 Sept 2026
These Commons divisions share a topic label. The question did not necessarily lead to a vote.
Recorded timeline
30 Aug 2024
Question tabled
To ask the Secretary of State for Health and Social Care, when NHS England last reviewed guidance for hyperemesis gravidarum; and whether that review was shared with (a) the Scottish Government and (b) NHS Scotland.
3 Sept 2024
Target answer date
Date supplied by the official written-questions record.
9 Sept 2024
Answer published
We recognise the challenges including the emotional and physical impacts that hyperemesis gravidarum can have on pregnant women and their families. Appropriate and evidence-based guidance is crucial.NHS England regularly reviews all health guidance, inclu...
Official data retrieved 27 Sept 2026.
Later records
Possible follow-up questions
Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.
Heart Diseases: Gender
20 Jan 2025 · To ask the Secretary of State for Health and Social Care, what training is provided to NHS staff to highlight the differences in symptoms of a heart attack between men and women.
Drugs: Gender
20 Jan 2025 · To ask the Secretary of State for Health and Social Care, what testing requirements are in place in the approval process to identify the different impacts of medicines on men and women.
Drugs: Gender
20 Jan 2025 · To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of differences in approved medicines on (a) men and (b) women.
Drugs: Women
20 Jan 2025 · To ask the Secretary of State for Health and Social Care, how many medicinal approvals used female physiology as a baseline for testing in each of the last five years.
Endometriosis: Research
20 Jan 2025 · To ask the Secretary of State for Health and Social Care, how much funding the Government has provided for endometriosis research in each of the last five years; and what proportion of Government-funded medicinal research that accounts for.
Mental Illness: Drugs
21 Feb 2025 · To ask the Secretary of State for Health and Social Care, whether the National Institute for Health and Care Research has undertaken research on the potential impact of psychedelic medication on the treatment of severe mental health conditions.
Health Services: National Security
23 Apr 2025 · To ask the Secretary of State for Health and Social Care, if he will conduct an audit of health infrastructure classified as critically important to national interests to identify whether they contain Chinese-made components.
Ritlecitinib: Alopecia
19 May 2025 · To ask the Secretary of State for Health and Social Care, what guidance his Department has issued to health boards on the prescription of Ritlecitinib to treat alopecia.
Ritlecitinib: Alopecia
19 May 2025 · To ask the Secretary of State for Health and Social Care, on what age of patient health boards are advised to use Ritlecitinib to treat alopecia.
Ritlecitinib: Alopecia
19 May 2025 · To ask the Secretary of State for Health and Social Care, what assessment he has made of the effectiveness of Severity of Alopecia Tool scores to determine the correct treatment of alopecia.
Alopecia: Medical Treatments
19 May 2025 · To ask the Secretary of State for Health and Social Care, what discussions he has had with the British Association of Dermatologists on the suitability of Severity of Alopecia Tool scores to determine treatment for alopecia.
Alopecia: Medical Treatments
19 May 2025 · To ask the Secretary of State for Health and Social Care, what guidance his Department has issued to health boards on the factors that should be used to determine the severity of alopecia prior to a decision on treatment.